Number of shares outstanding for Aurinia Pharmaceuticals (AUPH)

Number of shares outstanding as of September 2024 : 144,013,000

According to Aurinia Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 144,013,000. At the end of 2024 the company had 144,013,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Aurinia Pharmaceuticals from 1999 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.14 B	0.82%
2023	0.14 B	0.66%
2022	0.14 B	7.46%
2021	0.13 B	4.29%
2020	0.12 B	29.29%
2019	97.93 M	14.7%
2018	85.38 M	2.5%
2017	83.3 M	130.88%
2016	36.07 M	11.78%
2015	32.27 M	2.42%
2014	31.51 M	506.43%
2013	5.19 M	49.41%
2012	3.47 M	0%
2011	3.47 M	27.14%
2010	2.73 M	4.19%
2009	2.62 M	23.57%
2008	2.12 M	0%
2007	2.12 M	26.04%
2006	1.68 M	1.87%
2005	1.65 M	10.57%
2004	1.49 M	1.49%
2003	1.47 M	13.14%
2002	1.3 M	31.62%
2001	0.99 M	41.69%
2000	0.69 M	16.49%
1999	0.6 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Regeneron Pharmaceuticals REGN	108,100,000	-24.94%	🇺🇸 USA
Aeterna Zentaris AEZS	2,220,303	-98.46%	🇺🇸 USA
Pieris Pharmaceuticals PIRS	1,299,000	-99.10%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions